These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 4098508)

  • 21. Simultaneous induction of experimental allergic encephalomyelitis in obese strain (OS) chickens with spontaneous, hereditary autoimmune thyroiditis.
    Wick G; Steiner R
    J Immunol; 1972 Sep; 109(3):471-6. PubMed ID: 5055181
    [No Abstract]   [Full Text] [Related]  

  • 22. [Production of gamma globulins in the central nervous system during experimental allergic encephalomyelitis].
    Pozzuoli R; Musiani P
    Riv Patol Nerv Ment; 1969 Jun; 90(3):197-211. PubMed ID: 4107146
    [No Abstract]   [Full Text] [Related]  

  • 23. [The role of cellular factors in the pathogenesis of experimental allergic encephalomyelitis].
    Kanchurin AKh; Pozina IM
    Biull Eksp Biol Med; 1968 Nov; 66(11):28-30. PubMed ID: 5758118
    [No Abstract]   [Full Text] [Related]  

  • 24. In vivo and in vitro immunological cross-reactions between basic encephalitogen and synthetic basic polypeptides capable of suppressing experimental allergic encephalomyelitis.
    Webb C; Teitelbaum D; Arnon R; Sela M
    Eur J Immunol; 1973 May; 3(5):279-86. PubMed ID: 4128128
    [No Abstract]   [Full Text] [Related]  

  • 25. Reaginic antibody in experimental allergic encephalomyelitis. I. Characterization of heat-labile skin-fixing antibody.
    Moore MJ; Behan PO; Kies MW; Matthews JM
    Res Commun Chem Pathol Pharmacol; 1974 Sep; 9(1):119-32. PubMed ID: 4140559
    [No Abstract]   [Full Text] [Related]  

  • 26. Further studies on the inhibition of allergic encephalomyelitis by L-asparaginase.
    Khan A; Levine S
    J Immunol; 1974 Jul; 113(1):367-70. PubMed ID: 4134065
    [No Abstract]   [Full Text] [Related]  

  • 27. Delayed hypersensitivity studies in experimental allergic encephalomyelitis; a comparison of macrophage migration inhibition tests and electrophoretic mobility.
    Hughes D; Caspary EA; Field EJ
    Z Immunitatsforsch Exp Klin Immunol; 1970; 141(1):14-9. PubMed ID: 4251430
    [No Abstract]   [Full Text] [Related]  

  • 28. Delayed hypersensitivity to Trichinella spiralis. 3. Effect of repeated sensitizations in donors and recipients.
    Kim CW; Jamuar MP; Hamilton LD
    J Immunol; 1970 Jul; 105(1):175-86. PubMed ID: 4246565
    [No Abstract]   [Full Text] [Related]  

  • 29. Recovery of myelin basic protein reactive T cells from spinal cords of Lewis rats with autoimmune encephalomyelitis.
    Burns J; Rosenzweig A; Zweiman B; Moskovitz A; Lisak R
    J Immunol; 1984 Jun; 132(6):2690-2. PubMed ID: 6202757
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Experimental allergic encephalomyelitis in the Lewis rat: studies on the mechanism of recovery from disease and acquired resistance to reinduction.
    Willenborg DO
    J Immunol; 1979 Sep; 123(3):1145-50. PubMed ID: 313947
    [No Abstract]   [Full Text] [Related]  

  • 31. Protection of rats from experimental allergic encephalomyelitis with antiserum to guinea-pig spinal cord.
    Hughes RA
    Immunology; 1974 Apr; 26(4):703-11. PubMed ID: 4212280
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activation of effector cells in experimental allergic encephalomyelitis by interleukin 2 (IL-2).
    Ortiz-Ortiz L; Weigle WO
    J Immunol; 1982 Apr; 128(4):1545-50. PubMed ID: 6174605
    [No Abstract]   [Full Text] [Related]  

  • 33. Pathogenesis of experimental allergic orchitis. I. Transfer with immune lymph node cells.
    Tung KS; Unanue ER; Dixon FJ
    J Immunol; 1971 Jun; 106(6):1453-62. PubMed ID: 4932773
    [No Abstract]   [Full Text] [Related]  

  • 34. The effect of antisera against rat immunoglobulins on cellular transfer of experimental allergic encephalomyelitiin Lewis rats.
    Richardson WP; Paterson PY
    Clin Exp Immunol; 1970 Mar; 6(3):337-44. PubMed ID: 4191825
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulation of paralytic experimental allergic encephalomyelitis in rats: susceptibility to active and passive disease reinduction.
    Hinrichs DJ; Roberts CM; Waxman FJ
    J Immunol; 1981 May; 126(5):1857-62. PubMed ID: 6163820
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Suppression of experimental allergic encephalomyelitis with thoracic duct lymphocytes.
    Frost H; Swanborg RH
    Int Arch Allergy Appl Immunol; 1980; 63(2):153-8. PubMed ID: 6158482
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunosuppression of experimental allergic encephalomyelitis. III. In vitro evidence for induction of suppressor T lymphocytes in draining lymph node cells of animals immunized with myelin basic protein complexed to lipopolysaccharides.
    Raziuddin S; Kibler RF; Morrison DC
    J Immunol; 1982 May; 128(5):2073-80. PubMed ID: 6174621
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Experimental allergic encephalomyelitis: demyelinating activity of serum and sensitized lymph node cells on cultured nerve tissues.
    Bornstein MB; Iwanami H
    J Neuropathol Exp Neurol; 1971 Apr; 30(2):240-8. PubMed ID: 5147780
    [No Abstract]   [Full Text] [Related]  

  • 39. Transformation of lymphocytes from animals sensitized to Trichinella spiralis.
    Kim CW; Jamuar MP; Hamilton LD
    J Immunol; 1971 Nov; 107(5):1382-9. PubMed ID: 4256095
    [No Abstract]   [Full Text] [Related]  

  • 40. THE APPLICATION OF TISSUE CULTURE TO THE STUDY OF EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS. II. SERUM FACTORS RESPONSIBLE FOR DEMYELINATION.
    APPEL SH; BORNSTEIN MB
    J Exp Med; 1964 Feb; 119(2):303-12. PubMed ID: 14164484
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.